About Us

About us

At Alpinia we combine centuries old knowledge about traditional medicinal plants with scientific investigations. Cutting-edge technologies and modern scientific resources are used to develop products, that are the result of research by a dedicated team of experts who work to ensure quality, safety and efficacy of our health care and cosmetic products.


Since the establishment of the Alpinia Institute in 2008, the company has been pursuing the scientific development of medicines based on plants with high therapeutic potential.

Extracts are clinically tested in collaboration with renowned research institutes and hospitals. The institute is equipped with state-of-the-art research and development laboratories, along with an auditorium for scientific congresses, seminars and symposia events.


Medicinal plants are a common denominator for care and therapy across different time periods and civilizations, ranging from Indian Ayurveda, classic Greek and medieval Arabian to modern European medicine. By leveraging traditional knowledge, the Alpinia Institute of Phytopharmaceutical Sciences uses modern research methods and technologies to develop medical and health care products.

During our long pre-clinic research, analytical and pharmacological studies of our Frankincense extract have been carried out successfully in our labs in cooperation with renowned research institutions and organizations. The main constituents of the Frankincense extract have been identified, pharmacological activities have been investigated and a special capsule for oral administration, as well as a topical formulation has been developed.

MS Study

The Universitätsklinikum Hamburg Eppendorf (UKE) performed a phase IIa trial (SABA study, in patients with relapsing-remitting multiple sclerosis). Our Frankincense extract was applied as study medication. The patients were treated for eight months with an option to extend treatment for up to 36 months. Eighty patients were screened at two centers, 38 patients were included in the trial, 28 completed the 8-month treatment period and 18 of these participated in the extension period. The investigators considered this Frankincense extract to be safe in the applied doses, and exposure to it was beneficial for patients with relapsing-remitting multiple sclerosis.

(Stürner KH, et al. J Neurol Neurosurg Psychiatry 2018;89:330–338,


Frankincense is the naturally occurring resin of frankincense trees which belong to the botanical genus Boswellia and which are native to the hot and arid climate zones of eastern Africa, southern Arabia and the Indian subcontinent. The precious resin is collected by peeling the outer layer of the bark of a frankincense tree. After a few days the resin exuded at the treated zone is collected from the trunk and dried, cleaned and graded. Frankincense consists of a mixture of essential oil, mucilage polysaccharides and resinous acids and is defined as oleo gum resin.

Since the 1980s, frankincense has increasingly attracted scientific attention as an agent of potentially high medicinal value. To date, numerous pharmacological and clinical studies have been conducted, especially with Indian frankincense from Boswellia serrata which is now listed in the European Pharmacopoeia.

Meanwhile, an extensive body of laboratory data is available for frankincense, based on which a broad activity profile has been deduced including anti-inflammatory effects. Clinical data demonstrate the efficacy of frankincense extracts, in comparison to placebo or reference drugs, in arthritic conditions, chronic inflammatory diseases of the intestines, and bronchial asthma.

Frankincense and its extracts also reveal an exceedingly favourable preclinical and clinical safety profile and, in comparison to orally applied standard anti-inflammatory drugs, are less prone to cause adverse effects. Today, frankincense is being re-discovered also as a therapeutic for dermal application in various inflammatory skin conditions and different research groups currently explore the resin’s potential in this context.

Alpinia produces a special frankincense resin extract manufactured by using the highest – pharmaceutical – quality of resin obtained from the Indian frankincense tree Boswellia serrata and which preserves the valuable properties of frankincense.